Modeling erythroblastic islands: Using a hybrid model to assess the function of central macrophage

Journal of Theoretical Biology

Volumn 298, Issue , 2012, Pages 92-106

  Fischer, S ^a   Kurbatova, P ^b,c   Bessonov, N ^d   Gandrillon, O ^c,e   Volpert, V ^b,c   Crauste, F ^b,c  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INRIA RHÔNE ALPES   (France)

^d INSTITUTE OF PROBLEMS OF MECHANICAL ENGINEERING   (Russian Federation)

^e CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Erythroblastic island; Erythropoiesis; Hybrid model; Macrophage

Indexed keywords

CYTOKINE; GROWTH FACTOR;

APOPTOSIS; BLOOD; CELL ORGANELLE; PROTEIN; STOCHASTICITY;

APOPTOSIS; ARTICLE; BONE MARROW; CELL DEATH; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; CELL PROLIFERATION; CONTINUOUS MODEL; CONTROLLED STUDY; CYTOKINE RELEASE; ERYTHROBLAST; ERYTHROBLASTIC ISLANDS; ERYTHROID CELL; ERYTHROPOIESIS; EXTRACELLULAR SPACE; HYBRID MODEL; INTRACELLULAR SPACE; MACROPHAGE; MATHEMATICAL MODEL; MITOSIS SPINDLE; PRIORITY JOURNAL; REGULATORY MECHANISM;

BONE MARROW CELLS; CELL COMMUNICATION; ERYTHROBLASTS; ERYTHROPOIESIS; FEEDBACK, PHYSIOLOGICAL; HUMANS; MACROPHAGES; MODELS, BIOLOGICAL;

EID: 84856010987     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2012.01.002     Document Type: Article

References (72)

1. Ackleh A.S., Deng K., Ito K., Thibodeaux J. A structured erythropoiesis model with nonlinear cell maturation velocity and hormone decay rate. Math. Bios. 2006, 204:21-48.
2. Adimy M., Crauste F., Ruan S. Modelling hematopoiesis mediated by growth factors with applications to periodic hematological diseases. Bull. Math. Biol. 2006, 68(8):2321-2351.
3. Aispuru G.R., Aguirre M.V., Aquino-Esperanza J.A., Lettieri C.N., Juaristi J.A., Brandan N.C. Erythroid expansion and survival in response to acute anemia stress: the role of EPO receptor, GATA-1, Bcl-xL and caspase-3. Cell Biol. Int. 2008, 32(8):966-978.
4. Alarcon T. Modelling tumour-induced angiogenesis: a review of individual-based models and multiscale approaches. The Mathematics of Cancer and Developmental Biology. Contemporary Mathematics 2009, vol. 492:45-74.
5. Apostu R., Mackey M.C. Understanding cyclical thrombocytopenia: a mathematical modeling approach. J. Theor. Biol. 2008, 251:297-316.
6. Banks H.T., Cole C.E., Schlosser P.M., Hien T. Modelling and optimal regulation of erythropoiesis subject to benzene intoxication. Math. Biosci. Eng. 2004, 1(1):15-48.
7. Bauer A., Tronche F., Wessely O., Kellendonk C., Reichardt H.M., Steinlein P., Schütz G., Beug H. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev. 1999, 13(22):2996-3002.
8. Bélair J., Mackey M.C., Mahaffy J.M. Age-structured and two-delay models for erythropoiesis. Math. Biosci. 1995, 128:317-346.
9. Bernard S., Bélair J., Mackey M.C. Oscillations in cyclical neutropenia: new evidence based on mathematical modeling. J. Theor. Biol. 2003, 223:283-298.
10. Bernard S., Bélair J., Mackey M.C. Bifurcations in a white-blood-cell production model. C. R. Biol. 2004, 327:201-210.
11. Bessonov, N., Eymard, N., Gandrillon, O., Koury, M., Kurbatova, P., Mejia-Pous, C., Volpert, V. The Role of Spatial Organization of Cells in Erythropoiesis, submitted.
12. Bessonov, N., Crauste, F., Fischer, S., Kurbatova, P., Volpert, V. Application of hybrid models to blood cell production in the bone marrow. Math. Model. Nat. Phenom. 6 (7), 2-12.
13. Bessonov N., Kurbatova P., Volpert V. Particle dynamics modeling of cell populations. Math. Model. Nat. Phenom. 2010, 5(7):42-47.
14. Chapel S.H., Veng-Pedersen P., Schmidt R.L., Widness J.A. A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep. J. Pharmacol. Exp. Therapeut. 2000, 296:346-351.
15. Chappell D., Tilbrook P.A., Bittorf T., Colley S.M., Meyer G.T., Klinken S.P. Prevention of apoptosis in J2E erythroid cells by erythropoietin: involvement of JAK2 but not MAP kinases. Cell Death Differ. 1997, 4:105-113.
16. Chasis J.A., Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood 2008, 112(3):470-478.
17. Colijn C., Mackey M.C. A mathematical model of hematopoiesis-I. Periodic chronic myelogenous leukemia. J. Theor. Biol. 2005, 237:117-132.
18. Colijn C., Mackey M.C. A mathematical model of hematopoiesis-II. Cyclical neutropenia. J. Theor. Biol. 2005, 237:133-146.
19. Crauste F., Pujo-Menjouet L., Génieys S., Molina C., Gandrillon O. Adding self-renewal in committed erythroid progenitors improves the biological relevance of a mathematical model of erythropoiesis. J. Theor. Biol. 2008, 250:322-338.
20. Crauste F., Demin I., Gandrillon O., Volpert V. Mathematical study of feedback control roles and relevance in stress erythropoiesis. J. Theor. Biol. 2010, 263:303-316.
21. Dazy S., Damiola F., Parisey N., Beug H., Gandrillon O. The MEK-1/ERKs signaling pathway is differentially involved in the self-renewal of early and late avian erythroid progenitor cells. Oncogene 2003, 22:9205-9216.
22. Demin I., Crauste F., Gandrillon O., Volpert V. A multi-scale model of erythropoiesis. J. Biol. Dyn. 2010, 4:59-70.
23. De Maria R., Testa U., Luchetti L., Zeuner A., Stassi G., Pelosi E., Riccioni R., Felli N., Samoggia P., Peschle C. Apoptotic role of fas/fas ligand system in the regulation of erythropoiesis. Blood 1999, 93:796-803.
24. Eller J., Gyori I., Zollei M., Krizsa F. Modelling thrombopoiesis regulation-I. Model description and simulation results. Comput. Math. Appl. 1987, 14:841-848.
25. Foo J., Drummond M.W., Clarkson B., Holyoake T., Michor F. Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib. PLoS Comput. Biol. 2009, 5(9):e1000503.
26. Freise K.J., Widness J.A., Schmidt R.L., Veng-Pedersen P. Modeling time variant distributions of cellular lifespans increases in circulating reticulocyte lifespans: following double phlebotomies in sheep. J. Pharmacokinet. Pharmacodyn. 2008, 35:285-323.
27. Gandrillon O. The v-erbA oncogene. Assessing its differentiation-blocking ability using normal chicken erythrocytic progenitor cells. Methods Mol. Biol. 2002, 202:91-107.
28. Gandrillon O., Schmidt U., Beug H., Samarut J. TGF-beta cooperates with TGF-alpha to induce the self-renewal of normal erythrocytic progenitors: evidence for an autocrine mechanism. Embo J. 1999, 18:2764-2781.
29. Golubev A. Random discrete competing events vs. dynamic bistable switches in cell proliferation in differentiation. J. Theor. Biol. 2010, 267(3):341-354.
30. Haurie C., Dale D.C., Mackey M.C. Cyclical neutropenia and other periodic hematological diseases: a review of mechanisms and mathematical models. Blood 1998, 92:2629-2640.
31. Hoehme S., Drasdo D. A cell-based simulation software for multi-cellular systems. Bioinformatics 2010, 26(20):2641-2642.
32. Jelkmann W. Molecular biology of erythropoietin. Intern. Med. 2004, 43:649-659.
33. Jeon J., Quaranta V., Cummings P.T. An off-lattice hybrid discrete-continuum model of tumor growth and invasion. Biophys. J. 2010, 98(1):37-47.
34. Koury M.J., Bondurant M.C. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990, 248:378-381.
35. Mackey M.C. Unified hypothesis of the origin of aplastic anaemia and periodic hematopoïesis. Blood 1978, 51:941-956.
36. Mackey M.C. Dynamic hematological disorders of stem cell origin. Biophysical and Biochemical Information Transfer in Recognition 1979, 373-409. Plenum Press, New York. G. Vassileva-Popova, E.V. Jensen (Eds.).
37. Mackey M.C., Rudnicki R. Global stability in a delayed partial differential equation describing cellular replication. J. Math. Biol. 1994, 33:89-109.
38. Mackey M.C., Rudnicki R. A new criterion for the global stability of simultaneous cell replication and maturation processes. J. Math. Biol. 1999, 38:195-219.
39. Mahaffy J.M., Belair J., Mackey M.C. Hematopoietic model with moving boundary condition and state dependent delay: applications in erythropoiesis. J. Theor. Biol. 1998, 190:135-146.
40. Michor F., Hughes T.P., Iwasa Y., Branford S., Shah N.P., Sawyers C.L., Nowak M.A. Dynamics of chronic myeloid leukaemia. Nature 2005, 435(7046):1267-1270.
41. Michor F. Quantitative approaches to analyzing imatinib-treated chronic myeloid leukemia. Trends Pharmacol. Sci. 2007, 28(5):197-199.
42. Michor F. Mathematical models of cancer stem cells. J. Clin. Oncol. 2008, 26(17):1861-2854.
43. Nagata Y., Takahashi N., Davis R.J., Todokoro K. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 1998, 92:1859-1869.
44. Osborne J.M., Walter A., Kershaw S.K., Mirams G.R., Fletcher A.G., Pathmanathan P., Gavaghan D., Jensen O.E., Maini P.K., Byrne H.M. A hybrid approach to multi-scale modeling of cancer. Phil. Trans. R. Soc. A 2010, 368:5013-5028.
45. Pain B., Woods C.M., Saez J., Flickinger T., Raines M., Peyroll S., Moscovici C., Moscovici M.G., Kung H.J., Jurdic P., Lazarides E., Samaru J. EGF-R as a hemopoietic growth factor receptor: the c-erbB product is present in normal chicken erythrocytic progenitor cells and controls their self-renewal. Cell 1991, 65:37-46.
46. Patel A.A., Gawlinsky E.T., Lemieux S.K., Gatenby R.A. A cellular automaton model of early tumor growth and invasion: the effects of native tissue vascularity and increased anaerobic tumor metabolism. J. Theor. Biol. 2001, 213:315-331.
47. Ramis-Conde I., Chaplain M.A., Anderson A.R., Drasdo D. Multi-scale modeling of cancer cell intravasation: the role of cadherins in metastasis. Phys. Biol. 2009, 6(1):016008.
48. Rew D.A., Wilson G.D., Taylor I., Weaver P.C. Proliferation characteristics of human colorectal carcinomas measured in vivo. Br. J. Surg. 1991, 78:60-66.
49. Rhodes M.M., Kopsombut P., Bondurant M.C., Price J.O., Koury M.J. Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin. Blood 2008, 111:1700-1708.
50. Roeder I. Quantitative stem cell biology: computational studies in the hematopoietic system. Curr. Opin. Hematol. 2006, 13:222-228.
51. Rubiolo C., Piazzolla D., Meissl K., Beug H., Huber J.C., Kolbus A., Baccarini M. A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation. Blood 2006, 108:152-159.
52. Sadahira Y., Yasuda T., Yoshino T., Manabe T., Takeishi T., Kobayashi Y., Ebe Y., Naito M. Impaired splenic erythropoiesis in phlebotomized mice injected with CL2MDP-liposome: an experimental model for studying the role of stromal macrophages in erythropoiesis. J. Leukoc. Biol. 2000, 68:464-470.
53. Salazar-Ciudad I., Jernvall J. A computational model of teeth and the developmental origins of morphological variation. Nature 2010, 464(7288):583-586.
54. Santillan M., Mahaffy J.M., Belair J., Mackey M.C. Regulation of platelet production: the normal response to perturbation and cyclical platelet disease. J. Theor. Biol. 2000, 206:585-603.
55. Savill N.J., Chadwick W., Reece S.E. Quantitative analysis of mechanisms that govern red blood cell age structure and dynamics during anaemia. PLoS Comput. Biol. 2009, 5(6):e1000416.
56. Sawyer S.T., Jacobs-Helber S.M. Unraveling distinct intracellular signals that promote survival and proliferation: study of erythropoietin, stem cell factor, and constitutive signaling in leukemic cells. J. Hematother. Stem Cell Res. 2000, 9:21-29.
57. Secchiero P., Melloni E., Heikinheimo M., Mannisto S., Di Pietro R., Iacone A., Zauli G. TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Blood 2004, 103:517-522.
58. Spencer S.L., Gerety R.A., Pienta K.J., Forrest S. Modeling somatic evolution in tumorigenesis. PLoS Comput. Biol. 2006, 2(8):e108.
59. Spivak J.L., Pham T., Isaacs M., Hankins W.D. Erythropoietin is both a mitogen and a survival factor. Blood 1991, 77:1228-1233.
60. Scholz M., Engel C., Loeffler M. Modelling human granulopoiesis under poly-chemotherapy with G-CSF support. J. Math. Biol. 2005, 50(4):397-439.
61. Scholz M., Gross A., Loeffler M. A biomathematical model of human thrombopoiesis under chemotherapy. J. Theor. Biol. 2010, 264(2):287-300.
62. Socolovsky M. Molecular insights into stress erythropoiesis. Curr. Opin. Hematol. 2007, 14:215-224.
63. Sui X., Krantz S.B., Zhao Z.J. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways. Br. J. Haematol. 2000, 110:63-70.
64. Tsiftsoglou A.S., Vizirianakis I.S., Strouboulis J. Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life 2009, 61(8):800-830.
65. Veng-Pedersen P., Chapel S., Schmidt R.L., Al-Huniti N.H., Cook R.T., Widness J.A. An integrated pharmacodynamic analysis of erythropoietin, reticulocyte, and hemoglobin responses in acute anemia. Pharm. Res. 2002, 19:1630-1635.
66. Wichmann H.E., Gerhardts M.D., Spechtmeyer H., Gross R. A mathematical model of thrombopoiesis in rats. Cell Tissue Kinet. 1979, 12:551-567.
67. Wichman H.E., Loeffler M. Mathematical Modeling of Cell Proliferation 1985, CRC, Boca Raton, FL.
68. Wichmann H.E., Loeffler M., Schmitz S. A concept of hemopoietic regulation and its biomathematical realisation. Blood Cells 1985, 14:411-429.
69. Wichmann H.E., Loeffler M., Pantel K., Wulff H. A mathematical model of erythropoiesis in mice and rats. Part 2. Stimulated erythropoiesis. Cell Tissue Kinet. 1989, 22:31-49.
70. Woo S., Krzyzanski W., Jusko W.J. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats. J. Pharmacol. Exp. Ther. 2006, 319:1297-1306.
71. Woo S., Krzyzanski W., Jusko W.J. Pharmacodynamic model for chemotherapy-induced anemia in rats. Cancer Chemother. Pharmacol. 2008, 62:123-133.
72. Wulff H., Wichmann H.E., Loeffler M., Pantel K. A mathematical model of erythropoiesis in mice and rats. Part 3. Suppressed erythropoiesis. Cell Tissue Kinet. 1989, 22:51-61.